Kouri, Naomi
Murray, Melissa E.
Reddy, Joseph S.
Serie, Daniel J.
Soto-Beasley, Alexandra
Allen, Mariet
Carrasquillo, Minerva M.
Wang, Xue
Castanedes, Monica Casey
Baker, Matthew C.
Rademakers, Rosa
Uitti, Ryan J.
Graff-Radford, Neill R.
Wszolek, Zbigniew K.
Schellenberg, Gerard D.
Crook, Julia E.
Ertekin-Taner, Nilüfer
Ross, Owen A.
Dickson, Dennis W. https://orcid.org/0000-0001-7189-7917
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (UG3 NS104095)
National Institute of Neurological Disorders and Stroke (U54 NS100693)
National Institute of Neurological Disorders and Stroke (R01 NS78086)
National Institute of Neurological Disorders and Stroke (U54 NS100693)
National Institute on Aging (P30 AG062677)
National Institute on Aging (R01 AG054449)
National Institute on Aging (R01 AG56366)
U.S. Department of Defense (W81XWH-17-1-0249)
Biogen (228PD201)
Biohaven Pharmaceuticals (BHV4157-206)
Biohaven Pharmaceuticals (BHV3241-301)
Neuraly (NLY01-PD-1)
National Institutes of Health (P01 AG017586)
National Institutes of Health (U54 NS100693)
National Institutes of Health (UG3 NS104095)
Article History
Received: 23 November 2020
Revised: 15 February 2021
Accepted: 16 February 2021
First Online: 26 February 2021